Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
dARK ID: | ark:/48912/0013000015rr8 |
Texto Completo: | http://dx.doi.org/10.1186/s13098-017-0251-z https://repositorio.unifesp.br/handle/11600/53450 |
Resumo: | Background: Since the first position statement on diabetes and cardiovascular prevention published in 2014 by the Brazilian Diabetes Society, the current view on primary and secondary prevention in diabetes has evolved as a result of new approaches on cardiovascular risk stratification, new cholesterol lowering drugs, and new anti-hyperglycemic drugs. Importantly, a pattern of risk heterogeneity has emerged, showing that not all diabetic patients are at high or very high risk. In fact, most younger patients who have no overt cardiovascular risk factors may be more adequately classified as being at intermediate or even low cardiovascular risk. Thus, there is a need for cardiovascular risk stratification in patients with diabetes. The present panel reviews the best current evidence and proposes a practical risk-based approach on treatment for patients with diabetes. Main body: The Brazilian Diabetes Society, the Brazilian Society of Cardiology, and the Brazilian Endocrinology and Metabolism Society gathered to form an expert panel including 28 cardiologists and endocrinologists to review the best available evidence and to draft up-to-date an evidence-based guideline with practical recommendations for risk stratification and prevention of cardiovascular disease in diabetes. The guideline includes 59 recommendations covering: (1) the impact of new anti-hyperglycemic drugs and new lipid lowering drugs on cardiovascular risk |
id |
UFSP_203c1ea978cc4752332ce721400d04be |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/53450 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)Diabetes mellitusCardiovascular preventionCardiovascular screeningBlood glucoseRisk factorsCoronary artery diseaseDyslipidemiasHypertensionAntiplatelet agentsBackground: Since the first position statement on diabetes and cardiovascular prevention published in 2014 by the Brazilian Diabetes Society, the current view on primary and secondary prevention in diabetes has evolved as a result of new approaches on cardiovascular risk stratification, new cholesterol lowering drugs, and new anti-hyperglycemic drugs. Importantly, a pattern of risk heterogeneity has emerged, showing that not all diabetic patients are at high or very high risk. In fact, most younger patients who have no overt cardiovascular risk factors may be more adequately classified as being at intermediate or even low cardiovascular risk. Thus, there is a need for cardiovascular risk stratification in patients with diabetes. The present panel reviews the best current evidence and proposes a practical risk-based approach on treatment for patients with diabetes. Main body: The Brazilian Diabetes Society, the Brazilian Society of Cardiology, and the Brazilian Endocrinology and Metabolism Society gathered to form an expert panel including 28 cardiologists and endocrinologists to review the best available evidence and to draft up-to-date an evidence-based guideline with practical recommendations for risk stratification and prevention of cardiovascular disease in diabetes. The guideline includes 59 recommendations covering: (1) the impact of new anti-hyperglycemic drugs and new lipid lowering drugs on cardiovascular risk(2) a guide to statin use, including new definitions of LDL-cholesterol and in non-HDL-cholesterol targets(3) evaluation of silent myocardial ischemia and subclinical atherosclerosis in patients with diabetes(4) hypertension treatmentand (5) the use of antiplatelet therapy. Conclusions: Diabetes is a heterogeneous disease. Although cardiovascular risk is increased in most patients, those without risk factors or evidence of sub-clinical atherosclerosis are at a lower risk. Optimal management must rely on an approach that will cover both cardiovascular disease prevention in individuals in the highest risk as well as protection from overtreatment in those at lower risk. Thus, cardiovascular prevention strategies should be individualized according to cardiovascular risk while intensification of treatment should focus on those at higher risk.Univ Fed Rio Grande do Sul, Dept Med Interna, Fac Med, Rua Ramiro Barcelos 2400, BR-90035003 Porto Alegre, RS, BrazilUniv Fed Rio Grande do Sul, Hosp Clin Porto Algere, Serv Med Interna, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, RS, BrazilInst Estadual Diabet & Endocrinol Luiz Capriglion, Rua Moncorvo Filho 90, BR-20211340 Rio De Janeiro, BrazilFac Med Valenca, Rua Sebastiao Dantas Moreira 40, BR-27600000 Valenca, BrazilUniv Presidente Antonio Carlos FAME UNIPAC, Fac Med, Av Juiz de Fora 1100, BR-36048000 Juiz De Fora, MG, BrazilInst Dante Pazzanese Cardiol, Av Dante Pazzanese 500, BR-04012180 Sao Paulo, BrazilUniv Fed Sao Paulo UNIFESP, Rua Loefgren 1350, BR-04040001 Sao Paulo, BrazilUniv Fed Rio Grande do Sul, Rua Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, BrazilUniv Sao Paulo, Av Dr Eneas de Carvalho Aguiar 44, BR-05403000 Sao Paulo, BrazilFac Ciencias Med Minas Gerais, Alameda Ezequiel Dias 275, BR-30130110 Belo Horizonte, MG, BrazilUniv Fed Goias, Setor Leste Univ Goiania, 1 Avenida S-N, BR-74605020 Goiania, Go, BrazilPontificia Univ Catolica Campinas, Av John Boyd Dunlop S-N, BR-13059900 Campinas, SP, BrazilMed Santa Casa Sao Paulo, Fac Ciencias, Rua Dr Cesario Motta Jr 112, BR-01221020 Sao Paulo, BrazilUniv Fed Santa Catarina, Rua Profa Maria Flora Pausewang S-N, BR-88040970 Florianopolis, SC, BrazilClin Endocrinol & Metabol, Av Tancredo Neves 1632-708, BR-41820020 Salvador, BA, BrazilCtr Diabet Belo Horizonte, Rua Niquel 31, BR-30220280 Belo Horizonte, MG, BrazilFac Med Sao Jose Rio Preto, Av Brg Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, BrazilUniv Fed Sao Paulo, Rua Leandro Dupret 365, BR-04025011 Sao Paulo, SP, BrazilUniv Fed Sao Paulo, Rua Botucatu 740, BR-04023002 Sao Paulo, SP, BrazilUniv Fed Sao Paulo, Rua Leandro Dupret 365, BR-04025011 Sao Paulo, SP, BrazilUniv Fed Sao Paulo UNIFESP, Rua Loefgren 1350, BR-04040001 Sao Paulo, BrazilUniv Fed Sao Paulo, Rua Botucatu 740, BR-04023002 Sao Paulo, SP, BrazilWeb of ScienceAmgenMSDSanofi/RegeneronSanofiAmgenMSDSanofi/RegeneronSanofiBiomed Central Ltd2020-06-26T16:30:16Z2020-06-26T16:30:16Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttp://dx.doi.org/10.1186/s13098-017-0251-zDiabetology & Metabolic Syndrome. London, v. 9, p. -, 2017.10.1186/s13098-017-0251-zWOS000405816500001.pdf1758-5996https://repositorio.unifesp.br/handle/11600/53450WOS:000405816500001ark:/48912/0013000015rr8engDiabetology & Metabolic SyndromeLondoninfo:eu-repo/semantics/openAccessBertoluci, Marcello CasacciaMoreira, Rodrigo OliveiraFaludi, AndreIzar, Maria Cristina [UNIFESP]Schaan, Beatriz D.Valerio, Cynthia MelissaBertolami, Marcelo ChiaraChacra, Ana PaulaBolivar Malachias, Marcus ViniciusVencio, SergioKerr Saraiva, Jose FranciscoBetti, RobertoTuratti, LuizHelfenstein Fonseca, Francisco Antonio [UNIFESP]Bianco, Henrique Tria [UNIFESP]Sulzbach, MartaBertolami, AdrianaNunes Salles, Joao EduardoHohl, AlexandreTrujilho, FabioLima, Eduardo GomesMiname, Marcio HiroshiZanella, Maria Teresa [UNIFESP]Lamounier, RodrigoSa, Joao Roberto [UNIFESP]Amodeo, CelsoPires, Antonio CarlosSantos, Raul D.reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-03T03:25:19Zoai:repositorio.unifesp.br/:11600/53450Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:58:06.854709Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
title |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
spellingShingle |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) Bertoluci, Marcello Casaccia Diabetes mellitus Cardiovascular prevention Cardiovascular screening Blood glucose Risk factors Coronary artery disease Dyslipidemias Hypertension Antiplatelet agents |
title_short |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
title_full |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
title_fullStr |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
title_full_unstemmed |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
title_sort |
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) |
author |
Bertoluci, Marcello Casaccia |
author_facet |
Bertoluci, Marcello Casaccia Moreira, Rodrigo Oliveira Faludi, Andre Izar, Maria Cristina [UNIFESP] Schaan, Beatriz D. Valerio, Cynthia Melissa Bertolami, Marcelo Chiara Chacra, Ana Paula Bolivar Malachias, Marcus Vinicius Vencio, Sergio Kerr Saraiva, Jose Francisco Betti, Roberto Turatti, Luiz Helfenstein Fonseca, Francisco Antonio [UNIFESP] Bianco, Henrique Tria [UNIFESP] Sulzbach, Marta Bertolami, Adriana Nunes Salles, Joao Eduardo Hohl, Alexandre Trujilho, Fabio Lima, Eduardo Gomes Miname, Marcio Hiroshi Zanella, Maria Teresa [UNIFESP] Lamounier, Rodrigo Sa, Joao Roberto [UNIFESP] Amodeo, Celso Pires, Antonio Carlos Santos, Raul D. |
author_role |
author |
author2 |
Moreira, Rodrigo Oliveira Faludi, Andre Izar, Maria Cristina [UNIFESP] Schaan, Beatriz D. Valerio, Cynthia Melissa Bertolami, Marcelo Chiara Chacra, Ana Paula Bolivar Malachias, Marcus Vinicius Vencio, Sergio Kerr Saraiva, Jose Francisco Betti, Roberto Turatti, Luiz Helfenstein Fonseca, Francisco Antonio [UNIFESP] Bianco, Henrique Tria [UNIFESP] Sulzbach, Marta Bertolami, Adriana Nunes Salles, Joao Eduardo Hohl, Alexandre Trujilho, Fabio Lima, Eduardo Gomes Miname, Marcio Hiroshi Zanella, Maria Teresa [UNIFESP] Lamounier, Rodrigo Sa, Joao Roberto [UNIFESP] Amodeo, Celso Pires, Antonio Carlos Santos, Raul D. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Bertoluci, Marcello Casaccia Moreira, Rodrigo Oliveira Faludi, Andre Izar, Maria Cristina [UNIFESP] Schaan, Beatriz D. Valerio, Cynthia Melissa Bertolami, Marcelo Chiara Chacra, Ana Paula Bolivar Malachias, Marcus Vinicius Vencio, Sergio Kerr Saraiva, Jose Francisco Betti, Roberto Turatti, Luiz Helfenstein Fonseca, Francisco Antonio [UNIFESP] Bianco, Henrique Tria [UNIFESP] Sulzbach, Marta Bertolami, Adriana Nunes Salles, Joao Eduardo Hohl, Alexandre Trujilho, Fabio Lima, Eduardo Gomes Miname, Marcio Hiroshi Zanella, Maria Teresa [UNIFESP] Lamounier, Rodrigo Sa, Joao Roberto [UNIFESP] Amodeo, Celso Pires, Antonio Carlos Santos, Raul D. |
dc.subject.por.fl_str_mv |
Diabetes mellitus Cardiovascular prevention Cardiovascular screening Blood glucose Risk factors Coronary artery disease Dyslipidemias Hypertension Antiplatelet agents |
topic |
Diabetes mellitus Cardiovascular prevention Cardiovascular screening Blood glucose Risk factors Coronary artery disease Dyslipidemias Hypertension Antiplatelet agents |
description |
Background: Since the first position statement on diabetes and cardiovascular prevention published in 2014 by the Brazilian Diabetes Society, the current view on primary and secondary prevention in diabetes has evolved as a result of new approaches on cardiovascular risk stratification, new cholesterol lowering drugs, and new anti-hyperglycemic drugs. Importantly, a pattern of risk heterogeneity has emerged, showing that not all diabetic patients are at high or very high risk. In fact, most younger patients who have no overt cardiovascular risk factors may be more adequately classified as being at intermediate or even low cardiovascular risk. Thus, there is a need for cardiovascular risk stratification in patients with diabetes. The present panel reviews the best current evidence and proposes a practical risk-based approach on treatment for patients with diabetes. Main body: The Brazilian Diabetes Society, the Brazilian Society of Cardiology, and the Brazilian Endocrinology and Metabolism Society gathered to form an expert panel including 28 cardiologists and endocrinologists to review the best available evidence and to draft up-to-date an evidence-based guideline with practical recommendations for risk stratification and prevention of cardiovascular disease in diabetes. The guideline includes 59 recommendations covering: (1) the impact of new anti-hyperglycemic drugs and new lipid lowering drugs on cardiovascular risk |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 2020-06-26T16:30:16Z 2020-06-26T16:30:16Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1186/s13098-017-0251-z Diabetology & Metabolic Syndrome. London, v. 9, p. -, 2017. 10.1186/s13098-017-0251-z WOS000405816500001.pdf 1758-5996 https://repositorio.unifesp.br/handle/11600/53450 WOS:000405816500001 |
dc.identifier.dark.fl_str_mv |
ark:/48912/0013000015rr8 |
url |
http://dx.doi.org/10.1186/s13098-017-0251-z https://repositorio.unifesp.br/handle/11600/53450 |
identifier_str_mv |
Diabetology & Metabolic Syndrome. London, v. 9, p. -, 2017. 10.1186/s13098-017-0251-z WOS000405816500001.pdf 1758-5996 WOS:000405816500001 ark:/48912/0013000015rr8 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Diabetology & Metabolic Syndrome |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
- application/pdf |
dc.coverage.none.fl_str_mv |
London |
dc.publisher.none.fl_str_mv |
Biomed Central Ltd |
publisher.none.fl_str_mv |
Biomed Central Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1818602577672011776 |